Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries
- 14 February 2016
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 205, 147-156
- https://doi.org/10.1016/j.ijcard.2015.12.015
Abstract
No abstract availableFunding Information
- National Health and Medical Research Council of Australia (571456)
- European Commission 7th Framework Programme (241849)
- National Health and Medical Research Council (NHMRC) ((#457508, #402797, #632810)
- Health Research Council of New Zealand
- Heart Foundation of New Zealand
This publication has 17 references indexed in Scilit:
- Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVDJAMA, 2013
- Individual Participant Data Meta-Analysis for a Binary Outcome: One-Stage or Two-Stage?PLOS ONE, 2013
- The Efficacy and Tolerability of ‘Polypills’: Meta-Analysis of Randomised Controlled TrialsPLOS ONE, 2012
- Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular DiseasesCirculation: Cardiovascular Quality and Outcomes, 2012
- Improving adherence using combination therapy (IMPACT): Design and protocol of a randomised controlled trial in primary careContemporary Clinical Trials, 2011
- An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular RiskPLOS ONE, 2011
- A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health OrganizationTrials, 2011
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextThe Lancet, 1990